Fermenta Biotech Ltd — Important, 10-12-2025: Company Update

Fermenta Biotech's Board has approved a significant capital expenditure of Rs. 110 crore for its Dahej facility, phased across FY26-FY27. This investment aims to expand capacity for plant-based Vitamin D3 (leveraging a new patent and addressing vegan market demand) and Vitamin D3 derivatives, allocating Rs. 60 crore. An additional Rs. 50 crore will boost Green Chemistry Enzyme production (75KL fermentation capacity), driven by increasing customer acceptance and the pharmaceutical industry's shift towards sustainable processes. This strategic move reinforces Fermenta's leadership in high-value, sustainable nutritional and biocatalytic solutions.